ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,846.00
      0.00%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.695
      -0.76%
      Bitcoin
      63,060.43
      -2.76%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. IDEAYA Biosciences Inc (IDYA)

      7. IDEAYA Biosciences Inc (IDYA) News

      IDYA

      IDEAYA Biosciences (IDYA)

      IDEAYA Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDYA
      DateTimeSourceHeadlineSymbolCompany
      06/30/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      06/30/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/26/20234:28PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/22/20236:00AMPR Newswire (US)IDEAYA Announces First Reported Case of Uveal Melanoma Patient Spared Enucleation in Phase 1 Neoadjuvant IST with Darovasertib MonotherapyNASDAQ:IDYAIDEAYA Biosciences Inc
      06/12/20236:00AMPR Newswire (US)IDEAYA Announces Selection of IDE397 Phase 2 Monotherapy Expansion Dose For Global Enrollment Targeting High Priority MTAP-Deletion Solid Tumor TypesNASDAQ:IDYAIDEAYA Biosciences Inc
      06/09/20234:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/09/20234:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/09/20234:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/09/20234:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/09/20234:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/09/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/06/20236:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/30/20236:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Upcoming June 2023 Investor Relations EventsNASDAQ:IDYAIDEAYA Biosciences Inc
      05/26/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/24/20235:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/22/20234:39PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/22/20236:00AMPR Newswire (US)IDEAYA Announces IND Clearance Enabling Phase 1/2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP-Deletion Solid TumorsNASDAQ:IDYAIDEAYA Biosciences Inc
      05/16/20236:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/16/20236:00AMPR Newswire (US)IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      05/15/20236:24AMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/09/20234:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/09/20236:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/09/20236:00AMPR Newswire (US)IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
      05/01/20236:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Upcoming May 2023 Investor Relations EventNASDAQ:IDYAIDEAYA Biosciences Inc
      04/28/20236:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      04/27/20234:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
      04/27/20234:01PMPR Newswire (US)IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:IDYAIDEAYA Biosciences Inc
      04/26/20236:05AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDYAIDEAYA Biosciences Inc
      04/25/202312:15AMPR Newswire (US)IDEAYA Announces Pricing of Public OfferingNASDAQ:IDYAIDEAYA Biosciences Inc
      04/24/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:IDYA